Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8CNS 3Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1Agnosia 1Abdominal Pain 1

Interventions

Oxaliplatin 1435Fluorouracil 1316Capecitabine 1112Gemcitabine 1054Leucovorin 935Bevacizumab 845Irinotecan 827Cisplatin 673Radiotherapy 559Cetuximab 481pembrolizumab 435Paclitaxel 400Drug Therapy 358Nivolumab 349130-nm albumin-bound paclitaxel 326Docetaxel 289Sorafenib 288S 1 (combination) 278Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 256lenvatinib 222sintilimab 218tislelizumab 213durvalumab 211regorafenib 208Radiosurgery 204Magnetic Resonance Spectroscopy 203apatinib 202Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Transcranial Direct Current Stimulation × Gastrointestinal × Clear all
NCT02928237 2016-10-10

Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients

Assiut University

Phase NA Completed
40 enrolled
Gastrointestinal

Agnosia, Carcinoma, Hepatocellular, Abdominal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡